Evidence map›Paper›PMID 27207798›Full record

ReviewBlood2016

The role of whole brain radiation in primary CNS lymphoma.

Benjamin Kasenda, Jay Loeffler, Gerald Illerhaus, Andrés J M Ferreri, James Rubenstein, Tracy T Batchelor

Abstract readCase ReportsReview
In one paragraph

Review in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Primary central nervous system lymphoma.Nature reviews. Disease primers · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Diagnosis and Treatment of Primary CNS Lymphoma.Deutsches Arzteblatt international · 2018
    Article
  18. Article
  19. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.Hematology. American Society of Hematology. Education Program · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benjamin KasendaDepartment of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany;
Jay LoefflerDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA;
Gerald IllerhausDepartment of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany;
Andrés J M FerreriUnit of Lymphoid Malignancies, Department of Onco-Hematology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy;
James RubensteinDivision of Hematology/Oncology, San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;
Tracy T BatchelorPartners Neurology Residency Program, Harvard Medical School, Boston, MA; and Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA.

Funding

The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's LymphomaR01CA139083 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2009 to 2018
$3.4M
Targeted Therapies in CNS LymphomasR21CA184694 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JAMES LOUIS · 2014 to 2015
$378k
NCI NIH HHS R01 CA139083NCI NIH HHS R21 CA184694
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBrainBrain NeoplasmsChemoradiotherapyFemaleHumansLymphoma, Large B-Cell, DiffuseMiddle AgedRandomized Controlled Trials as Topic

Identifiers

PMID27207798
PMCPMC4968379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.